FindTrial
Sign In

The clinical study of the treatment of ocular tumors with Cyberknife

The clinical study of the treatment of ocular tumors with Cyberknife

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-16010098
Enrollment
Unknown
Registered
2016-12-07
Start date
2016-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ocular tumors

Interventions

Case series:Cyberknife treatment

Sponsors

Tianjin Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients with primary or metastatic tumors of the eyes

Exclusion criteria

Exclusion criteria: 1. Local lesions are not suitable for SRS; 2. Body poor constitution could not accept SRS.

Design outcomes

Primary

MeasureTime frame
local control rate;—

Countries

China

Contacts

Public ContactHongqing Zhuang

Tianjin Cancer Hospital

yiduzhengmu@163.com+86 13752272283

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026